Quickly Spot Consensus Among the World's Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
218%
upside
3 price targets
|
0
%
|
|
|
|
174%
upside
4 price targets
|
0
%
|
|
|
|
121%
upside
5 price targets
|
0
%
|
|
|
4
Ocular Therapeutix
OCUL
$2.48B
|
100%
upside
7 price targets
|
0
%
|
|
|
89%
upside
3 price targets
|
0
%
|
|
|
|
85%
upside
6 price targets
|
0
%
|
|
|
|
85%
upside
6 price targets
|
0
%
|
|
|
|
84%
upside
11 price targets
|
0
%
|
|
|
|
82%
upside
3 price targets
|
0
%
|
|
|
|
80%
upside
10 price targets
|
0
%
|
|
|
11
Crinetics Pharmaceuticals
CRNX
$4.2B
|
76%
upside
7 price targets
|
0
%
|
|
|
75%
upside
5 price targets
|
0
%
|
|
|
|
72%
upside
4 price targets
|
0
%
|
|
|
|
71%
upside
3 price targets
|
0
%
|
|
|
|
71%
upside
8 price targets
|
0
%
|
|
|
|
68%
upside
4 price targets
|
0
%
|
|
|
|
68%
upside
3 price targets
|
0
%
|
|
|
|
68%
upside
7 price targets
|
0
%
|
|
|
|
67%
upside
9 price targets
|
0
%
|
|
|
|
66%
upside
10 price targets
|
0
%
|
|
|
|
65%
upside
9 price targets
|
0
%
|
|
|
|
62%
upside
11 price targets
|
0
%
|
|
|
|
62%
upside
7 price targets
|
0
%
|
|
|
|
61%
upside
5 price targets
|
0
%
|
|
|
|
60%
upside
3 price targets
|
0
%
|
|